Welcome to our dedicated page for Envista Holdings Corporation news (Ticker: NVST), a resource for investors and traders seeking the latest updates and insights on Envista Holdings Corporation stock.
Envista Holdings Corporation (NYSE: NVST) is a leading global dental products company committed to empowering dental professionals worldwide. Headquartered in Brea, California, Envista develops, manufactures, and markets an extensive portfolio of dental consumables, equipment, and services. The company operates through two primary segments: Specialty Products & Technologies and Equipment & Consumables.
The Specialty Products & Technologies segment focuses on dental implant systems, regenerative solutions, dental prosthetics, orthodontic systems, and lab products. This segment is dedicated to advancing the capabilities of dental professionals through innovative products and technologies.
The Equipment & Consumables segment offers a broad range of dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization and magnification systems, supporting the diagnostic, treatment, and prevention needs of dental conditions.
Envista has a strong commitment to continuous improvement, action-oriented innovation, and a deep respect for dental professionals. Its comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs, ensuring a holistic approach to dental care.
Recent achievements include the launch of the DEXIS digital ecosystem, an AI-powered platform designed to streamline implant dentistry workflows. This interconnected system combines cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning, empowering clinicians to manage implant cases efficiently.
Envista continues to innovate with products like the ORTHOPANTOMOGRAPH™ OP 3D™ LX, which enhances 3D diagnostic capabilities, and the IS ScanFlow software, which integrates AI-driven tools to maximize productivity in dental practices.
Financially, Envista reported sales of $623.6 million for the first quarter of 2024, with core sales growth and ongoing investments aimed at accelerating growth and profitability. The company has a proven track record of resilience and strategic differentiation, particularly through the challenges posed by the global pandemic and other economic factors.
Envista's philanthropic arm, the Envista Smile Project, exemplifies its commitment to social responsibility. The project has donated millions to improve access to oral health for underserved communities, partnering with institutions like the University of Southern California to enhance dental care for vulnerable populations.
Envista's significant market positions in attractive dental segments, coupled with its continuous improvement culture and innovation-driven approach, make it a pivotal player in the dental industry. For more information, visit the official website at www.envistaco.com.
Envista Holdings Corporation (NYSE: NVST) will release its first-quarter 2023 financial results on May 3, 2023. A conference call discussing these results is scheduled for the same day at 2:00 PM PT, lasting approximately one hour. The call will be accessible via a dial-in number and will also be webcast on the company's website. Post-presentation, a replay will be available for one year. Envista is a leading global dental products company, supporting professionals with a diverse portfolio that includes dental implants, orthodontics, and digital imaging technologies.
Envista Holdings Corporation (NYSE: NVST) has announced the registration for its third annual Envista Summit, to be held in Anaheim, California, from February 15-17, 2024. The event aims to unite the dental community, showcasing innovations and workflow improvements through presentations and hands-on workshops. The successful 2023 Summit in Las Vegas attracted nearly 1,500 professionals, featuring over 100 experts and extensive training sessions. Envista's CEO, Amir Aghdaei, emphasizes the goal of empowering dental practices through advanced tools and knowledge. Registrants can earn continuing education credits while enhancing patient care and operational efficiency.
Envista Holdings Corporation (NYSE: NVST) reported a 1.4% increase in sales to $660.8 million for Q4 2022, with core sales growth of 2.3% year-over-year. Net income reached $73.5 million, or $0.42 per diluted share, while adjusted net income rose to $91.9 million ($0.52 per diluted share), up from $81.1 million ($0.46) in Q4 2021. Adjusted EBITDA was $138.3 million, compared to $120.7 million the previous year. For 2023, Envista anticipates low-single digit core sales growth and an adjusted EBITDA margin exceeding 20%.
On January 30, 2023, Envista Holdings Corporation (NYSE: NVST) announced an Investor Access Event scheduled for February 24, 2023, from 8:00 am to 10:00 am PT at the Envista Summit. This hybrid event will feature a management presentation followed by a Q&A session. The Envista Summit aims to provide dental professionals with premium training across specialties like implantology, orthodontics, and endodontics, alongside digital dentistry training. For further details, visit the Envista Summit website.
FAQ
What is the current stock price of Envista Holdings Corporation (NVST)?
What is the market cap of Envista Holdings Corporation (NVST)?
What does Envista Holdings Corporation do?
What are the main segments of Envista's business?
What recent achievements has Envista made?
How did Envista perform financially in the first quarter of 2024?
What is the Envista Smile Project?
Who is the new CEO of Envista Holdings Corporation?
How does Envista support dental professionals?
What is the DEXIS digital ecosystem?
What is the Envista Business System (EBS)?
Where can I find more information about Envista Holdings Corporation?
